Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion

This study is testing whether a cholesterol-lowering drug called atorvastatin (a common statin) can reduce ongoing inflammation in the lungs and body after a patient has finished tuberculosis treatment. Even after TB is cured, some patients experience lasting inflammation that can damage the lungs. Researchers want to see if a statin can help. **You may be eligible if...** - You are between 18 and 65 years old and weigh between 50–90 kg - You have completed a full 24-week standard course of TB treatment and are considered cured - Your TB sputum culture was negative at week 16 of treatment - If you have HIV: you must be on antiretroviral therapy for at least 12 weeks, have a suppressed viral load, and a CD4 count above 350 - Your liver enzymes (AST and ALT) are within normal range **You may NOT be eligible if...** - You are currently on or recently completed TB treatment (must have finished the full course) - Your liver function tests are significantly elevated Talk to your doctor to see if this trial is right for you.